The Messenger, Not the Message: Rethinking Eosinophils as Biomarkers for Biologic Therapy in COPD
Blood eosinophil counts have become the entry criterion for biologic therapy in chronic obstructive pulmonary disease (COPD). However, the eosinophil-selected programmes produced mixed results, and the 2026 alarmin trials reduced exacerbations without any eosinophil threshold. We re-read the published primary and subgroup estimates of 16 randomised trials and asked whether eosinophil gradients behave as predictive or merely prognostic markers. Within populations already enriched at 300 cells/µL, higher counts did not consistently predict larger effects: the rate ratio for counts of 500 cells/µL or more versus fewer was 0.51 versus 0.80 in BOREAS but 0.70 versus 0.65 in NOTUS. In contrast, exhaled nitric oxide of 20 ppb or more was associated with a larger dupilumab effect in the same direction in both trials (pooled approximate interaction p = 0.009). Tozorakimab reduced exacerbations across all eosinophil strata, with a gradient (0.77 to 0.57; approximate interaction p = 0.077) that is suggestive but statistically inconclusive. Astegolimab showed no modification by eosinophils or smoking status. We propose that blood eosinophils are a downstream messenger of an upstream epithelial–alarmin endotype rather than the therapeutic target itself. Blood eosinophils remain a simple and useful marker of risk and enrichment, but selection may need to move from a single-cell threshold to composite endotypes that combine exposure history, airway biomarkers and structural traits. Further studies are warranted, designed to test treatment-by-biomarker interactions prospectively.
Authors
- Angelo Coppola (ORCID: https://orcid.org/0000-0002-0819-5936)
- Simone Ielo (ORCID: https://orcid.org/0009-0002-2838-423X)
- Alexandru Corlăteanu (ORCID: https://orcid.org/0000-0002-3278-436X)
- Pier‐Valerio Mari (ORCID: https://orcid.org/0000-0002-3307-217X)
- Lorenzo Carriera (ORCID: https://orcid.org/0009-0006-2538-1278)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Azienda Ospedaliera di Perugia (IT)
- ASL Roma (IT)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Ospedale San Filippo Neri (IT)
- Nicolae Testemițanu State University of Medicine and Pharmacy (MD)
- Ospedale San Donato (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/jcm15229069
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00